Tositumomab

In the US, Tositumomab (tositumomab systemic) is a member of the following drug classes: CD20 monoclonal antibodies, radiologic conjugating agents.

US matches:

• Tositumomab


• Tositumomab Intravenous


• Tositumomab and Iodine 131I-Tositumomab

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC,V09X,V10XA53

CAS registry number (Chemical Abstracts Service)

0208921-02-2

Chemical Formula

C6416-H9874-N1688-O1987-S44

Molecular Weight

143860

Therapeutic Categories

Antineoplastic agent

Immunomodulator

Monoclonal antibody

Chemical Name

Immunoglobulin G2a anti-(human antigen CD 20) (mouse monoclonal clone B1R1 gamma 2a-chain), disulfide with mouse monoclonal clone B1R1 £ x-chain, dimer

Foreign Names

• Tositumomabum (Latin)
• Tositumomab (German)
• Tositumomab (French)
• Tositumomab (Spanish)

Generic Names

• US 5595721 (IS)
• CD-20-iodine 131 (IS)
• SB-393229 (IS)
• Tositumomab iodine 131I (IS)

Brand Names

• Bexxar
  GlaxoSmithKline, Canada; GlaxoSmithKline, United States



• Iodine 131I-Tositumomab
  MDS Nordion, United States



• Tositumomab
  McKesson, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.